Research finds half of public would not visit pharmacy for minor illnesses

About The Authors

16th January 2017 16:10 - Pharmaceutical

Research finds half of general public would not visit pharmacy for minor illnesses: A recent market research report from the Proprietary Association of Great Britain (PAGB) has revealed that even though the general public realises the importance of self-care, many have claimed that the pharmacy would not be the first place they would go for advice about treating a minor ailment, such as colds and coughs.Research finds half of public would not visit pharmacy for minor illnesses

The survey of 5,011 UK adults aged between 18 and 75 was conducted by PAGB, which is a trade association that represents the manufacturers of branded over-the-counter drugs, food supplements and self-care medical devices.

Of the respondents in the survey, 47 per cent said that they would not visit the pharmacist if they had a minor condition. A further 33 per cent said that they would bypass the pharmacist and go straight to their GP even though 92 per cent of the respondents said that people should take responsibility for their own health to decrease the pressure on the National Health Service.

18 per cent of the respondents who said that they would not visit a pharmacist for advice about a minor illness believed that pharmacists are not as qualified as GPs or those who work in hospitals. However, 80 per cent of the survey respondents said that they thought accident and emergency services and GPs should not be used unless it is vital.

To conclude, the PAGB survey findings revealed a disconnect between the public’s good intentions on self-care and how they use the NHS themselves.

The survey findings have come during a time whereby there are calls for a national minor ailment scheme in pharmacies throughout England, similar to the long-running minor ailment scheme in Scotland.

Sign up for free insights from your sector…

Antispam code: 18029

Support Us..

We hope that you have found this article useful. This section is freely available for all to use. Please help support it by liking us or following us on our social media platforms:

Share this article..

For updated Pharmaceutical insights please follow us on @DJS_Pharma or use our RSS feed

Other Pharmaceutical Research Findings

Other Latest Market Research Insights

© DJS Research 2017